info@biomedres.us   +1 (720) 414-3554   600 Third Avenue, 2nd floor, New York - 10016, USA
ISSN: 2574 -1241
Impact Factor 0.548

Research ArticleOpen Access

Preparation and Preliminary Evaluation of Epigallocatechin Gallate Microcapsules on Gallbladder Cancer Cell Growth

Volume 3 - Issue 5

Francisca Acevedo*1,2, Barbara Mora-Lagos3,4, Claudia Sanhueza2,5, Javier Torres2, Kurt Buchegger4,6, Carmen Ili4,6, Priscilla Brebi4,6 and Mónica Rubilar2,7

  • Author Information Open or Close
    • 1Department of Basic Sciences, Faculty of Medicine, Universidad de La Frontera, Chile
    • 2Scientific and Technological Bioresource Nucleus, BIOREN, Universidad de La Frontera, Chile
    • 3Doctoral Program in Sciences, Universidad de La Frontera, Chile
    • 4Center of Excellence in Translational Medicine, Universidad de La Frontera, Chile
    • 5Doctoral Program in Science of Natural Resources, Universidad de La Frontera, Chile
    • 6Department of Pathological Anatomy, Universidad de La Frontera, Casilla Chile
    • 7Department of Chemical Engineering, Universidad de La Frontera, Chile

    *Corresponding author: F Acevedo, Department of Basic Sciences, Faculty of Medicine, Universidad de La, Scientific and Technological Bioresource Nucleus, Casilla 54-D, Temuco, Chile, Tel: +56452596711; Fax: +56 45 2732402; Email: francisca.acevedo@ufrontera.cl

Received: April 02, 2018;   Published: April 13, 2018

DOI: 10.26717/BJSTR.2018.03.000962

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Background: Gallbladder cancer is a highly lethal pathology, mainly due to late diagnosis and poor therapeutic alternatives. Epigallocatechin gallate (EGCG) has been reported as a cancer chemoprophylaxis, but its low stability and bioavailability limit its utility. The purpose of this study was to define the optimal process conditions by nano spray drying for EGCG microencapsulation using gum arabic and maltodextrin as a wall material and to test its chemopreventive action efficiency on gallbladder cancer cell lines (GB-d1).

Methods: For microcapsule production using a Büchi nanospray dryer, an experimental Taguchi design was applied using a L4(23) matrix. The effects of cytotoxicity and reactive oxygen species (ROS) production on GB-d1 cells in the presence of microencapsulated EGCG were assessed.

Results: A high EGCG loading efficiency (≥99%) obtained under optimal process conditions was the result. Microencapsulated EGCG triggered a considerable increase in cellular cytotoxicity compared with free EGCG; however, no statistically significant differences were found in ROS levels of microencapsulated and free EGCG (p≥0.05).

Conclusion: Based on these results, the microencapsulation technology enabled the successful encapsulation of EGCG, enhancing its antitumor effect on gallbladder cancer cells.

Keywords: Antitumor activity; Maltodextrin; Gum arabic; Encapsulation; Epigallocatechin gallate

Abstract| Introduction| Methods| Results| Discussion| Conclusion| Acknowledgement| References|